Government Plan to Fight Antibiotic-Resistant Bacteria Announced

The President's Council of Advisors on Science and Technology (PCAST) has released the report Combating Antibiotic Resistance to the President in conjunction with the National Strategy on Combating Antibiotic Resistant Bacteria and the Presidential Executive Order on the importance of addressing this concerning issue.

AACE/ACE Position Statement: Obesity is a Chronic Disease

The American Association of Clinical Endocrinologist (AACE) and the American College of Endocrinology (ACE) announced the publication of its position statement that describes its framework for a new diagnosis of obesity as a chronic disease.

Lymphoseek Gains Orphan Drug Designation for Head, Neck Cancer Detection

Lymphoseek Gains Orphan Drug Designation for Head, Neck Cancer Detection

Navidea announced that the Food and Drug Administration (FDA) has granted Lymphoseek (technetium Tc 99m tilmanocept) injection an Orphan Drug Designation for use in sentinel lymph node detection in patients with head and neck cancer.

Xultophy Shows Improved Glycemic Control, Weight Loss in T2DM

Novo Nordisk announced new data from the Phase 3a DUAL clinical trial comparing Xultophy (insulin degludec and liraglutide [IDegLira]) to insulin degludec (Tresiba) and liraglutide (Victoza) alone in insulin-naive and insulin-treated patients.

Effects of Antihypertensives Last for T2DM Patients, Even After Stopping Tx

Reductions in heart events and death last for many years after stopping therapy in patients with type 2 diabetes that take antihypertensives, Australian researchers have found.

Trulicity Pen Approved for Type 2 Diabetes

The Food and Drug Administration (FDA) has approved Trulicity (dulaglutide; Eli Lilly) pen as adjunct to diet and exercise to improve glycemic control in in adults with type 2 diabetes.

Head, Neck Cancer Cancer Drug May Overcome Cetuximab Resistance

Head, Neck Cancer Cancer Drug May Overcome Cetuximab Resistance

The investigational drug alpelisib (previously known as BYL719) appears to inhibit activation of the pathway that leads to resistance to cetuximab, an anti-epidermal growth factor receptor agent used in the treatment of head and neck cancer.

Healthcare Personnel Should Receive Flu Vaccine Yearly, Says ACIP

The Advisory Committee on Immunization Practice (ACIP) recommends that all healthcare personnel (HCP) be vaccinated against influenza every year.

Cyramza + Paclitaxel Demonstrates Efficacy in Cancer Trial

Eli Lilly and Company announced results from a global Phase 3 study with Cyramza (ramucirumab) in combination with paclitaxel for patients with advanced gastric cancer or gastroesophageal junction (GEJ) adenocarcinoma.

FDA Approves Stendra's Rapid Onset of Action

Vivus and Auxilium announced that the Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for Stendra (avanafil) to be taken ~15 minutes before sexual activity in the treatment of erectile dysfunction.

Baxter Recalls Mislabled Lot of Potassium Chloride Injection

Baxter Recalls Mislabled Lot of Potassium Chloride Injection

Baxter announced a voluntary recall of one lot of Potassium Chloride Injection 10mEq/100mL at the hospital/pharmacy/nurse level.

Greater Awareness of Dementia Risk Factors Needed

Reducing dementia risk factors should be incorporated into national and global public health programs alongside other major non-communicable diseases (NCD), urges the organization Alzheimer's Disease International.

Omarigliptin Significantly Lowers HbA1c Levels in Trial

Merck announced results from the Phase 3 clinical program for omarigliptin, once-weekly DPP-4 inhibitor for the treatment of type 2 diabetes.

Orthopedists Release Choosing Wisely Recommendations

The American Orthopaedic Foot & Ankle Society (AOFAS) has released a list of tests and procedures that are commonly ordered but not always necessary.

Memantine for Fibromyalgia: Results from First Randomized, Controlled Study

It is suspected that glutamate (Glu), an excitatory CNS neurotransmitter, may have a role in the pathophysiology of fibromyalgia; memantine, an N-methyl-D-aspartate (NMDA) receptor antagonist, could assist in reducing glutamate's neurotoxic effect by preventing the entry of excess calcium.

CDC Advises Clinicians on Rare Respiratory Illness Outbreak

CDC Advises Clinicians on Rare Respiratory Illness Outbreak

The Centers for Disease Control and Prevention (CDC) has issued an update regarding the outbreak of severe respiratory illness caused by the rare Enterovirus D68 (EV-D68) and recommendations for clinicians.

First-in-Class Movantik Approved for Opioid-Induced Constipation

The Food and Drug Administration has approved Movantik (naloxegol; AstraZeneca) for the treatment of opioid-induced constipation in adults with chronic non-cancer pain.

Eylea Granted Breakthrough Therapy for Diabetic Retinopathy

The Food and Drug Administration (FDA) has granted Eylea (afilbercept; Regeneron) Injection Breakthrough Therapy designation for the treatment of diabetic retinopathy in patients with diabetic macular edema (DME).

Chocolate-Flavored OTC Cough/Cold Products Launched

Chocolate-Flavored OTC Cough/Cold Products Launched

infirst Healthcare announced the launch of the Dr. Cocoa for Children product line, which consists of 3 over-the-counter (OTC) cough and cold medicines with 10% real cocoa for real chocolate taste to improve compliance.

First Glucose Meter with Insulin Calculator Available

First Glucose Meter with Insulin Calculator Available

Roche announced the launch of Accu-Chek Aviva Expert system, the first blood glucose meter with a built-in insulin calculator.

Lynovex Designated Orphan Drug for Cystic Fibrosis

The Food and Drug Administration (FDA) has granted Orphan Drug designation to Lynovex (NM001; NovaBiotics) for the treatment of cystic fibrosis (CF).

Uceris Rectal Foam for Distal Ulcerative Colitis Granted Tentative Approval

Uceris Rectal Foam for Distal Ulcerative Colitis Granted Tentative Approval

Salix announced that the Food and Drug Administration (FDA) has granted tentative approval for Uceris (budesonide) rectal foam for the induction of remission in patients with active mild-to-moderate distal ulcerative colitis (UC) extending up to 40cm from the anal verge.

NLA Issues New Dyslipidemia Management Recommendations

The National Lipid Association (NLA) has released new recommendations for the management of dyslipidemia that incorporate the need for a multifaceted approach incorporating each patient risk and risk factors, rather than specific medication categories.

Odanacatib Reduces Fracture Risk in Postmenopausal Women

Merck announced results from the Phase 3 LOFT study with odanacatib in postmenopausal women with osteoporosis.

New SC Inj for Primary Immunodeficiency Approved

New SC Inj for Primary Immunodeficiency Approved

Baxter and Halozyme announced that the Food and Drug Administration has approved Hyqvia (immune globulin infusion 10% [human] with recombinant human hyaluronidase) for adult patients with primary immunodeficiency (PI).

Rixubis Gains Pediatric Hemophilia B Indication

Rixubis Gains Pediatric Hemophilia B Indication

Baxter announced that the Food and Drug Administration (FDA) has approved Rixubis (coagulation factor IX [recombinant]) for routine prophylaxis, control, and prevention of bleeding episodes, and perioperative management in children with hemophilia B.

Hidden Ingredients Found in Multiple Weight Loss Supplements

The Food and Drug Administration (FDA) is warning consumers that several products promoted and sold for weight loss have been found to contain undeclared ingredients and should not be purchased or used.

Aleve PM Available for Overnight Pain Relief

Aleve PM Available for Overnight Pain Relief

Bayer HealthCare announced the launch of Aleve PM (naproxen and diphenhydramine) caplets for occasional sleeplessness associated with minor aches and pains.

FDA to Review Tuzistra XR NDA for Cough Cold

The Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) for review for Tuzistra XR (CCP-01; Vernalis and Tris Pharma) in the acute treatment of cough cold.

Vyvanse Under Review for Binge Eating Disorder

The Food and Drug Administration (FDA) has accepted for filing Shire's supplemental New Drug Application (sNDA) with priority review for Vyvanse (lisdexamfetamine dimesylate) Capsules (CII) for the treatment of adults with binge eating disorder (BED).

First-in-Class Test to Predict Liver, Intestine Transplant Rejection in Children

Plexison announced that the Food and Drug Administration (FDA) has approved Pleximmune, a first-in-class blood test to predict acute cellular rejection of transplanted livers and intestines in children.

Inflammation May Drive Blood Vessel Damage in Diabetes Patients

A new study suggests that inflammation may be the driving force behind damage to blood vessels caused by elevated blood glucose levels, with the potential for the use of anti-inflammatory medications in reducing the risk of blood vessel disease in patients with diabetes.

New Wrist-Worn Device Monitors Parkinson's Symptoms, Sends Medication Reminders

New Wrist-Worn Device Monitors Parkinson's Symptoms, Sends Medication Reminders

Global Kinetics Corporation has announced that it has received marketing clearance for their Personal KinetiGraph (PKG), the first wrist-worn device approved in the U.S. to improve the assessment and monitoring of symptoms of Parkinson's disease and other neurological disorders that impact movement.

Saxenda for Obesity Recommended by FDA Panel

A Food and Drug Administration (FDA) Advisory Committee has voted in favor of recommending liraglutide for chronic weight management in individuals with obesity or who are overweight with at least one weight-related comorbidity

Heparin Sodium Recalled Due to Visible Particulate

Hospira has announced a voluntary nationwide user-level recall of one lot of Heparin Sodium Injection due to a confirmed customer report of particulate in a single unit.

Tecifdera Efficacious for Relapsing-Remitting Multiple Sclerosis

Biogen Idec announced five-year results from the ENDORSE Phase 3 extension study with Tecfidera (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis (RRMS).

Plegridy Maintains Efficacy in Relapsing Multiple Sclerosis Trial

Plegridy Maintains Efficacy in Relapsing Multiple Sclerosis Trial

Biogen Idec announced new data from the second year of its Phase 3 ADVANCE clinical trial for Plegridy (peginterferon beta-1a) in patients with relapsing forms of multiple sclerosis (RMS).

Results for Humira in Chronic Skin Disease Trial

AbbVie announced results from the Phase 3 PIONEER 1 study with Humira (adalimumab) in patients with moderate-to-severe hidradenitis suppurativa (HS).

FDA Designates Antifungal Agent Orphan Drug Status

The Food and Drug Administration (FDA) has granted Orphan Drug designation to VT-1129 (Viamet Pharmaceuticals), a selective oral antifungal agent, for the treatment of cryptococcal meningitis.

Xtandi Approved for Metastatic Castration-Resistant Prostate Cancer

Xtandi Approved for Metastatic Castration-Resistant Prostate Cancer

Astellas and Medivation announced that the Food and Drug Administration has approved a new indication for Xtandi (enzalutamide) capsules for the treatment of patients with metastatic castration-resistant prostate cancer (CRPC).

New Combo Tablet for Weight Management Approved

Takeda and Orexigen announced that the Food and Drug Administration (FDA) has approved Contrave (naltrexone HCl and bupropion HCl) extended-release tablets as adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults

First Male Contraceptive Injection to Undergo Testing in 2015

First Male Contraceptive Injection to Undergo Testing in 2015

Vasalgel, the first male contraceptive injection, is anticipated to enter its first clinical trial beginning in 2015, according to the Parsemus Foundation.

Over 90% of Kids Exceed Recommended Sodium Intake

Over 90% of Kids Exceed Recommended Sodium Intake

Over 90% of school-age children in the United States are consuming more than the recommended daily allowance of sodium, with 10 common food types contributing to over 40% of the total sodium consumed by children, according to the Centers for Disease Control and Prevention (CDC).

Beware of Sterile Drugs from Downing Labs/NuVision, Warns FDA

The Food and Drug Administration (FDA) is warning healthcare professionals and consumers again about all sterile-use drug products made and distributed by Downing Labs LLC/NuVision.

Dopamine May Explain Overeating in Obese, Says Study

Obese adults may be more susceptible to environmental food cues than lean adults due to differences in brain chemistry that make eating more habitual and less rewarding, according a new study.

Mangos May Lower Blood Sugar in Obese, Study Suggests

Mangos May Lower Blood Sugar in Obese, Study Suggests

Regular consumption of mango by obese adults may lower blood sugar levels without a negative impact on body weight, a recent study suggests.

Needle-Free Lidocaine Delivery System Launched

Needle-Free Lidocaine Delivery System Launched

Marathon announced the launch of Zingo (lidocaine HCl monohydrate) powder intradermal injection system for the management of venous access pain.

Rolapitant NDA Submitted for Chemotherapy-Induced Nausea and Vomiting

Tesaro has submitted a New Drug Application (NDA) to the FDA for approval of oral rolapitant for the prevention of chemotherapy-induced nausea and vomiting (CINV).

Nintedanib Efficacious in Idiopathic Pulmonary Fibrosis Trials

Boehringer Ingelheim announced results from a pre-specified, pooled subgroup sensitivity analysis from the Phase 3 INPULSIS-1 and INPULSIS-2 trials that evaluated the use of nintedanib in patients with idiopathic pulmonary fibrosis (IPF) based on the severity of lung function impairment at baseline.

Early Preeclampsia Detection Test Under Development

Early Preeclampsia Detection Test Under Development

DiabetOmics announced a new point-of-care test to detect preeclampsia, assess the severity of the disease, and monitor its complications in as early as the 1st trimester.

Tiotropium Improves Lung Function in Asthma Patients

Boehringer Ingelheim announced results from its Phase 3 UniTinA-asthma trial program evaluating tiotropium in adults, adolescents, and pediatric patients with different severities of asthma.

New Drug for Alcohol Use Disorder to Undergo Clinical Trial

A six-month clinical trial to evaluate gabapentin enacarbil (Horizant; XenoPort) as a potential treatment for alcohol use disorder (AUD) is set to begin in the first half of 2015, the National Institute on Alcohol Abuse and Alcoholism (NIAAA) reported.

Menactra Gets OK for Booster Vaccination

Menactra Gets OK for Booster Vaccination

Sanofi Pasteur announced that the Food and Drug Administration (FDA) has approved the use of Menactra (meningococal [Groups A, C, Y, W-135] polysaccharide diphtheria toxoid conjugate vaccine) for booster vaccination against meningococcal disease in patients aged 15-55 years.

CDC: Rare Respiratory Virus Outbreak Reported in Over 1000 Children in the U.S.

CDC: Rare Respiratory Virus Outbreak Reported in Over 1000 Children in the U.S.

The Centers for Disease Control and Prevention (CDC) has issued an update on an outbreak of severe respiratory illness in over 1,000 children in at least 10 states caused by a rare enterovirus.

DEA: Pharmacies, Clinics Now Rx Drop-Off Sites

DEA: Pharmacies, Clinics Now Rx Drop-Off Sites

The United States Department of Justice (DOJ) has announced the creation of a new Drug Enforcement Agency (DEA) regulation that would allow pharmacies, hospitals, clinics, and other authorized collectors to serve as authorized drop-off sites for unused prescription medications.

Isavuconazole Under Review for Invasive Fungal Infections

The Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for isavuconazole (Astellas) for the treatment of invasive aspergillosis and invasive mucormycosis.

Ambrisentan + Tadalafil Efficacious for Pulmonary Arterial Hypertension

Ambrisentan + Tadalafil Efficacious for Pulmonary Arterial Hypertension

Gilead Sciences announced results from the Phase 3 AMBITION) study with ambrisentan and tadalafil for the treatment of pulmonary arterial hypertension.

Positive Results for Reslizumab in Asthma Trials

Teva announced positive results from its Phase 3 studies of reslizumab in patients with uncontrolled moderate to severe asthma with elevated eosinophils, treated with standard of care therapies.

Epaned Oral Solution Gains Two New Indications

Epaned Oral Solution Gains Two New Indications

Silvergate announced that the Food and Drug Administration (FDA) has approved Epaned (enalapril maleate powder for oral solution) for two additional indications.

Once-Weekly Pen for Diabetes Launched

Once-Weekly Pen for Diabetes Launched

AstraZeneca announced the availability of Bydureon (exenatide extended-release for injectable suspension) Pen in pharmacies across the country.

First-of-Kind Kidney Injury Risk Test Gets FDA Nod

First-of-Kind Kidney Injury Risk Test Gets FDA Nod

The Food and Drug Administration (FDA) announced that it has allowed marketing of the NephroCheck test, a first-of-a-kind laboratory test to assist in determining if some critically ill hospitalized patients are at risk of developing moderate-to-severe acute kidney injury (AKI) in the 12 hours post-test.

Ferric Citrate OK'd for Hyperphosphatemia in CKD Patients

Keryx Biopharmaceuticals announced that the Food and Drug Administration (FDA) has approved Ferric Citrate (formerly known as Zerenex) for the control of serum phosphorus levels in patients with chronic kidney disease (CKD) on dialysis.

Pharmacist Arrested in Fungal Meningitis Outbreak Case

Pharmacist Arrested in Fungal Meningitis Outbreak Case

The Boston division of the Federal Bureau of Investigation (FBI) has announced the arrest of a former supervising pharmacist at the New England Compounding Center (NECC) on one count of mail fraud related to a nationwide fungal meningitis outbreak.

First-in-Class Melanoma Drug Gets Accelerated Approval

The Food and Drug Administration (FDA) has granted accelerated approval for Keytruda (pembrolizumab; Merck) for the treatment of advanced or unresectable melanoma in patients who are no longer responsive to other drugs.

Crab's Blood: The Unlikely Bacteria Fighter

Crab's Blood: The Unlikely Bacteria Fighter

The humble horseshoe crab is an unlikely source of an extract used in the limulus amebocyte lysate (LAL) contamination test, but declining population numbers are driving the development of new tests to detect bacteria on medical equipment.

First Suicide Prevention Report Issued by WHO

The World Health Organization (WHO) has issued its first report on suicide prevention to increase awareness of suicide and suicide attempts, as well as urge governments to develop comprehensive suicide prevention strategies.

Basal Insulin Peglispro Efficacious in Type 1 Diabetes Trials

Basal Insulin Peglispro Efficacious in Type 1 Diabetes Trials

Eli Lilly and Company announced results from its IMAGINE-1 and IMAGINE-3 Phase 3 trials with basal insulin peglispro (BIL) in patients with type 1 diabetes.

FDA Fast Tracks Pulmaquin for Chronic Lung Infections

The Food and Drug Administration (FDA) has granted Fast Track status to Pulmaquin for the treatment of non-cystic fibrosis bronchiectasis (non-CF BE) patients who develop chronic lung infections with Pseudomonas aeruginosa.

Relebactam Designated Qualified Infectious Disease Product Status for Complicated Infections

The Food and Drug Administration (FDA) has granted Qualified Infectious Disease Product with designated Fast Track status to relebactam (MK-7655; Merck) for intravenous use, in the treatment complicated urinary tract infections, complicated intra-abdominal infections, and hospital-acquired bacterial pneumonia/ventilator-associated bacterial pneumonia.

First Human Milk-Based Premature Infant Formula Available

First Human Milk-Based Premature Infant Formula Available

Prolacta Bioscience announced the launch of Prolact RTF, the first ready-to-feed (RTF) human milk-derived premature infant formula.

You Can No Longer Buy Cigarettes at CVS

You Can No Longer Buy Cigarettes at CVS

The national drug store chain CVS Health (formerly CVS Caremark) announced that it has removed cigarettes and tobacco products from the shelves of all 7,700 locations, ahead of its previously targeted date.

Eravacycline Efficacious in Complicated Urinary Tract Infections Study

Tetraphase announced positive results from the lead-in portion of its IGNITE 2 clinical trial with IV and oral formulations of eravacycline for the treatment of complicated urinary tract infections (cUTI).

QlearQuil Line Launched for Sinus and Allergy Symptoms

Vicks announced the launch of QlearQuil, a line of over-the-counter (OTC) products for the treatment of sinus and allergy symptoms.

Eliquis Effective in Reducing All-Cause Hospitalization in Phase 3 Trial

Bristol-Myers Squibb and Pfizer announced results from the pre-specified secondary analysis of the Phase 3 AMPLIFY-EXT trial with Eliquis (apixaban).

Somatuline Depot sNDA Under Review for Gastoenteropancreatic Neuroendocrine Tumors

The Food and Drug Administration (FDA) has accepted and granted Priority Review to Ipsen's sNDA for Somatuline Depot (lanreotide acetate) 120mg injection for the treatment of gastoenteropancreatic neuroendocrine tumors (GEP-NETs).

Myelofibrosis Drug Granted Orphan Drug Status

The Food and Drug Admnistration (FDA) has granted Orphan Drug designation for PRM-151 (Promedior) for the treatment of myelofibrosis.

Nuplazid Designated Breakthrough Therapy for Parkinson's Disease Psychosis

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to Nuplazid (pimavanserin; Acadia Pharmaceuticals) for the treatment of Parkinson's disease psychosis.

Alirocumab Demonstrates Efficacy in Four Phase 3 Trials

Sanofi and Regeneron announced positive results from four Phase 3 ODYSSEY trials of alirocumab in patients with hypercholesterolemia.

FDA Grants Qualified Infectious Disease Product Status to Two Anti-Infectives

The Food and Drug Administration (FDA) has granted Wockhardt Limited's investigational anti-infectives, WCK 771 and WCK 2349 Qualified Infectious Disease Product (QDIP) status.

First Neurogenic Orthostatic Hypotension Drug Launched

First Neurogenic Orthostatic Hypotension Drug Launched

Lundbeck announced the availability of Northera (droxidopa) capsules for the treatment of orthostatic dizziness and lightheadedness in adult patients with symptomatic neurogenic orthostatic hypotension (NOH).

Updated Phase 3 Efficacy Results for Ampio

Ampio announced an update to the Phase 3 multicenter, double-blind STEP study of Ampion for osteoarthritis (OA) of the knee.

Xarelto as an Alternative to VKAs: New Study Results Issued

Janssen has announced results from its Phase 3b exploratory trial evaluating the efficacy of Xarelto (rivaroxaban) as an alternative to vitamin K antagonists (VKAs) for treating and reducing the risk of blood clots in non-valvular atrial fibrillation (NVAF) in patients undergoing elective cardioversion.

APD811 Designated Orphan Drug for Pulmonary Arterial Hypertension

The Food and Drug Administration (FDA) has granted Orphan Drug designation to APD811 (Arena Pharmaceuticals) for the treatment of pulmonary arterial hypertension (PAH).

Combination Ovarian Cancer Therapy Granted Fast Track Status

The Food and Drug Administration (FDA) has granted Fast Track designation to motolimod (VTX-2337; VentiRx) in combination with pegylated liposomal doxorubicin (PLD) for the treatment of women with ovarian cancer whose disease has progressed on or recurred after platinum-based chemotherapy.

RegeneSlim Recall Includes Four Additional Lots

RegeneSlim Recall Includes Four Additional Lots

Regeneca Worldwide announced the expansion of its voluntary nationwide recall of RegeneSlim appetite control dietary supplements to include four additional lots.

Ebola Traced to Single Animal Source, Spread at Funeral

Ebola Traced to Single Animal Source, Spread at Funeral

The origin of the latest Ebola outbreak has been traced to a single transmission from animal to human that spread during the course of a funeral.

New Biosensor Monitors Vital Signs, Detects Falls

New Biosensor Monitors Vital Signs, Detects Falls

Vital Connect announced that the Food and Drug Administration (FDA) has granted clearance for its HealthPatch MD biosensor for 24-hour patient monitoring in their homes.

Elelyso Gains Pediatric Gaucher Disease Indication

Elelyso Gains Pediatric Gaucher Disease Indication

Pfizer and Protalix BioTherapeutics announced that the Food and Drug Administration (FDA) has approved Elelyso (taliglucerase alfa) for injection for pediatric patients.

Pioglitazone, Bladder Cancer Risk: No Link in 10-Year Study

Pioglitazone, Bladder Cancer Risk: No Link in 10-Year Study

Takeda announced their completion and data submission of a 10-year epidemiology study to regulatory authorities, including the United States Food and Drug Administration (FDA).

BLA for Novel Cholesterol Drug Submitted to FDA

BLA for Novel Cholesterol Drug Submitted to FDA

Amgen announced that it has submitted a Biologics License Application (BLA) to the Food and Drug Administration (FDA) for evolocumab for the treatment of high cholesterol.

FDA Fast Tracks Clostridium Difficile Vaccine

The Food and Drug Administration (FDA) has granted Fast Track status for Pfizer's investigational Clostridium difficile (C. difficile) vaccine candidate (PF-06425090).

Experimental Ebola Vaccine Testing Accelerated for Human Trials

An experimental Ebola vaccine, being co-developed by the United States National Institutes of Health (NIH) and GlaxoSmithKline, is to undergo accelerated human trials with funding from an international consortium in response to the epidemic.

First Treatment for Common Anemia Shows Promise

A recent study has demonstrated potential for lexaptepid pegol as the first treatment for anemia of inflammation, the most common form of anemia.

Chronic Heart Failure Drug Designated Priority Review Status

Chronic Heart Failure Drug Designated Priority Review Status

The Food and Drug Administration (FDA) has granted Priority Review to Amgen's New Drug Application (NDA) for ivabradine for the treatment of chronic heart failure.

First-in-Class Drug Gains New Indication for Severe Aplastic Anemia

First-in-Class Drug Gains New Indication for Severe Aplastic Anemia

GlaxoSmithKline announced that the Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for the use of Promacta (eltrombopag) in patients with severe aplastic anemia (SAA) who have had an insufficient response to immunosuppressive therapy (IST).

Doctor Dies After Receiving Experimental Ebola Drug

Doctor Dies After Receiving Experimental Ebola Drug

Dr. Abraham Borbor, a Liberian doctor who contracted Ebola, has died after receiving one of the last doses of the experimental drug ZMapp.

Sulfonylurea Use, Cardiovascular Disease Connection Reviewed

In women with diabetes, long-term use of sulfonylureas may be associated with an increased risk of developing coronary heart disease (CHD), says a new study published in the journal Diabetes Care.

Will That Extra Cup of Coffee Lead to Death?

In a new study published in the American Journal of Therapeutics, data from the National Health and Nutrition Examination Survey III was used to determine whether coffee has an effect on cardiovascular and all-cause mortality.

Does Naltrexone Work for Impulse Control Disorders in Parkinson's Disease?

Does Naltrexone Work for Impulse Control Disorders in Parkinson's Disease?

A new study published in the journal Neurology looks at the use of naltrexone, an opioid antagonist, as a possible treatment for impulse control disorders (ICDs) in Parkinson's disease (PD).

Dangers Associated with the Ice Bucket Challenge

Dangers Associated with the Ice Bucket Challenge

While the Ice Bucket Challenge has raised significant funds for the ALS Association, there are risks associated with the stunt when it's done incorrectly.

Sign Up for Free e-newsletters